Who Owns Brainlab?
Brainlab is owned by Brainlab SE, a privately held Munich medical technology company controlled by founder Stefan Vilsmeier and investor EMH Partners. Founded in 1989, Brainlab develops image-guided surgery, surgical navigation, and radiosurgery platforms used in roughly 4,000 hospitals across 120 countries. A planned Frankfurt IPO was postponed in July 2025.
Who Owns Brainlab?
- Parent Company: Brainlab SE
- Ownership Type: Wholly owned
- Company Type: Privately Held
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Brainlab | Brainlab SE | Wholly owned |
Where to Buy
Disclosure: We may earn commission from purchases
Brainlab on AmazonAdvertisement
History of Brainlab
- Founded: 1989
- Founders: Stefan Vilsmeier
Stefan Vilsmeier founded Brainlab in Munich in 1989, funding it with proceeds from a computer graphics book he had written as a teenager after leaving a computer science degree. Its first product, a menu-driven surgical planning and navigation program, launched in 1990.
The 1990s and 2000s turned that software into complete navigation systems for neurosurgery, then radiosurgery through the Novalis program and the ExacTrac positioning platform. Growth ran at roughly 10 percent annually for two decades, funded internally and later by EMH Partners.
Product generations since have added the Curve navigation platform, the Kick optical system, the Loop-X mobile imaging robot, and the Cirq robotic arm, moving Brainlab from a software vendor to an integrated digital surgery company. The 2024 leadership transition put Vilsmeier into the board chair and Birkenbach into the CEO role, and the 2025 SE conversion and attempted IPO were meant to open the next phase. The listing was pulled at the last minute, but the underlying business, about 470 million euros of mostly recurring revenue, continued.
Advertisement
About Brainlab SE
Is Brainlab publicly traded? No. Brainlab is privately held. It postponed a planned Frankfurt Stock Exchange IPO in July 2025 and has said a listing remains under consideration.
Who owns Brainlab? Founder Stefan Vilsmeier owns roughly half the company, private equity firm EMH Partners holds about 35 percent, and employees and others hold the balance. Vilsmeier chairs the Administrative Board; Rainer Birkenbach is CEO.
What does Brainlab make? Surgical navigation and planning software and hardware for neurosurgery, spine, ENT, and orthopedic procedures, plus radiosurgery and radiotherapy planning systems such as ExacTrac.
Where is Brainlab headquartered? Munich, Germany, at Olof-Palme-Strasse 9. It employs about 2,100 people across 23 to 25 locations and sells in about 120 countries.
Advertisement
- Founded: 1989
- Headquarters: Munich, Bavaria, Germany
- Company Type: Privately Held
- Revenue: Approximately EUR 470 million (FY2023/24, ended September 2024)
- Employees: Approximately 2,100
Where Is Brainlab Made / Based?
- Headquarters: Munich, Bavaria, Germany
- Manufacturing / Operations: Germany
Brainlab Categories & Tags
Brainlab Sustainability & Ethics
The 2025 SE conversion included a new employee participation agreement, and the company frames its mission around digitizing medical workflows for better outcomes. As a primarily software business its direct environmental footprint is limited.
Brainlab Ownership: Pros & Cons
Advantages
- +Software-heavy recurring revenue produces strong margins
- +Vendor-neutral navigation works across implant brands
- +4,000-hospital installed base creates high switching costs
- +Founder control enables long product cycles
Considerations
- -Postponed IPO limits access to capital for robotics competition
- -Competes with Medtronic and Stryker at a fraction of their scale
- -Two shareholders control most of the company
Sources & Further Reading
Advertisement
Competitors to Brainlab
No direct competitors found in the same category. This could be because Brainlaboperates in a unique market segment or we're still building our competitor database.
Advertisement
Independent Alternatives to Brainlab
Looking for brands with different ownership structures? These similar brands are not owned by Brainlab SE, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Publicly Traded
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsAlcon
Owned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
eye-carecontact-lensesophthalmic
Publicly Traded
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsAmgen
Owned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
biotechnologypharmaceuticalsbiologics
Publicly Traded
Amgen operates independently without a large parent corporation.
Healthcare PharmaceuticalsAstraZeneca
Owned by AstraZeneca PLC
British-Swedish pharmaceutical brand behind Tagrisso and Farxiga, owned by publicly traded AstraZeneca PLC formed by merger in 1999.
pharmaceuticalsprescription-drugsoncology
Publicly Traded
AstraZeneca operates independently without a large parent corporation.
Healthcare PharmaceuticalsBoehringer Ingelheim
Owned by Boehringer Ingelheim
German family-owned pharmaceutical brand behind Jardiance and Spiriva, founded in 1885 and still controlled by the Boehringer family.
pharmaceuticalsprescription-drugsanimal-health
Privately Owned
Boehringer Ingelheim operates independently without a large parent corporation.
Healthcare PharmaceuticalsEli Lilly
Owned by Eli Lilly and Company
American pharmaceutical brand behind Mounjaro and Zepbound, owned by publicly traded Eli Lilly and Company founded in Indianapolis in 1876.
pharmaceuticalsprescription-drugsdiabetes
Publicly Traded
Eli Lilly operates independently without a large parent corporation.
Jobs at Brainlab SE
Advertisement
Latest News About Brainlab
Related Articles About Brainlab
View more articles
Health
Dental Brand Ownership Beyond Colgate and Crest
Colgate holds 41.3% global toothpaste share. P&G (Crest, Oral-B) has 14.1%. Haleon (Sensodyne) has 4.4%. Church & Dwight is the only independent at scale. The oral care market is $47.2B. Explore our database.
Who Brands StaffNov 12, 2026
ColgateCrestOral B
Health
Health Insurance Brand Ownership: The Big Players
UnitedHealth is #1 ($112B Q2 revenue, 26% MA share). CVS/Aetna is #3 ($106.1B Q2). Humana is #2 in MA (19.8%). Elevance is #2 by enrollment. Discover health insurance brand ownership. Explore our database.
Who Brands StaffNov 11, 2026
UnitedhealthAetnaCvs Health
Health
Organic Food Brand Ownership: Still Independent?
Annie's is General Mills ($820M). Cascadian Farm is General Mills (since 1999). Stonyfield is Lactalis (via Danone, $875M). Kashi is Kellogg's. Honest Tea was Coca-Cola (discontinued). Explore our database.
Who Brands StaffNov 9, 2026
Organic FoodAnniesCascadian Farm
Advertisement
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandmedical-devices
Abbott Medical Devices
Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.
Brand in Healthcare & Pharmaceuticals
cardiovasculardiabetes-care
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization